• Intrinsic Factor Blocking Antibody
  • Triglycerides, Body Fluid
  • HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
  • Anthrax DNA by Molecular Method
  • Hypothyroidism
  • Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis
  • Hereditary Angioedema Diagnostic Panel
  • Protein, Total, Body Fluid
  • FoundationFocus CDxBRCA
  • Lysozyme (Muramidase), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood
Medical Test

Overview
Access to Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood is restricted.